Kenyan patients who spend more than three days in the nation’s hospitals are more likely to harbor a form of bacteria resistant to one of the most widely used antibiotic classes, according to a recent study led by Washington State University.
Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 05.09.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed